(Q34128746)

PubMed publication ID

31 July 2017

1 reference

title

Switching between intravenous and oral pantoprazole (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6746342&resulttype=core&format=json

12 May 2020

author name string

J R Pisegna

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6746342&resulttype=core&format=json

12 May 2020

publication date

1 January 2001

1 reference

PubMed publication ID

11154164

Journal of Clinical Gastroenterology

31 July 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6746342&resulttype=core&format=json

12 May 2020

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6746342&resulttype=core&format=json

12 May 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6746342&resulttype=core&format=json

12 May 2020

page(s)

27-32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6746342&resulttype=core&format=json

Efficacy and safety of pantoprazole in patients with gastroesophageal reflux disease using an intravenous-oral regimen. Austrian Intravenous Pantoprazole Study Group.

12 May 2020

cites work

1 reference

12 December 2020

Inhibition of pentagastrin-induced gastric acid secretion by intravenous pantoprazole: a dose-response study

1 reference

12 December 2020

Oral and intravenous dosage forms of pantoprazole are equivalent in their ability to suppress gastric acid secretion in patients with gastroesophageal reflux disease

1 reference

12 December 2020

Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers

1 reference

12 December 2020

The potential clinical role of intravenous omeprazole

1 reference

12 December 2020

Intravenous omeprazole in patients with Zollinger-Ellison syndrome undergoing surgery

1 reference

12 December 2020

Pentagastrin-stimulated gastric acid secretion and pharmacokinetics following single and repeated intravenous administration of the gastric H+, K(+)-ATPase-inhibitor pantoprazole (BY1023/SK&F96022) in healthy volunteers.

1 reference

12 December 2020

Effect of i.v. omeprazole on the pH and volume of gastric contents before surgery.

1 reference

12 December 2020

Drug absorption in gastrointestinal disease and surgery

1 reference

12 December 2020

Stress ulcer prophylaxis in medical patients: who, what, and how much?

1 reference

12 December 2020

Effect of isopropamide on response to oral cimetidine in patients with Zollinger--Ellison syndrome.

1 reference

12 December 2020

Why do apparently healthy people use antacid tablets?

1 reference

12 December 2020

Guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Practice Parameters Committee of the American College of Gastroenterology

1 reference

12 December 2020

Intravenous administration of lansoprazole: a preliminary study of dose ranging and efficacy in upper gastrointestinal bleeding

1 reference

12 December 2020

Inhibitory Effects of Intravenous Lansoprazole on Gastric Acid Hypersecretion in Patients with Postoperative Stress

1 reference

12 December 2020

A double-blind study of pantoprazole and omeprazole in the treatment of reflux oesophagitis: a multicentre trial

1 reference

12 December 2020

A double-blind study of pantoprazole and ranitidine in treatment of acute duodenal ulcer. A multicenter trial. European Pantoprazole Study Group

1 reference

12 December 2020

Endoscopic ultrasonographic evaluation of gastric ulcer healing on treatment with proton pump inhibitors versus H2-receptor antagonists.

1 reference

12 December 2020

Reflux oesophagitis and its treatment.

1 reference

12 December 2020

Intravenous administration of the proton pump inhibitor omeprazole reduces the risk of acid aspiration at emergency cesarean section

1 reference

12 December 2020

Prospective study of efficacy and safety of lansoprazole in Zollinger-Ellison syndrome.

1 reference

12 December 2020

Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses

1 reference

12 December 2020

A comparison of lansoprazole, omeprazole, and ranitidine for reducing preoperative gastric secretion in adult patients undergoing elective surgery.

1 reference

12 December 2020

Lansoprazole and omeprazole in the treatment of acid peptic disorders.

1 reference

12 December 2020

Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis. The Lansoprazole Group

1 reference

12 December 2020

Lack of pantoprazole drug interactions in man: an updated review

1 reference

12 December 2020

Pantoprazole and omeprazole in the treatment of reflux oesophagitis: a European multicentre study.

1 reference

12 December 2020

A prospective study of simplified omeprazole suspension for the prophylaxis of stress-related mucosal damage.

1 reference

12 December 2020

Contemporary medical therapy for gastroesophageal reflux disease

1 reference

12 December 2020

Proton pump inhibitory therapy: then and now.

1 reference

12 December 2020

Pharmacotherapy for acid/peptic disorders.

1 reference

12 December 2020

Optimizing the pharmacology of acid control in acid-related disorders

1 reference

12 December 2020

Therapeutic approaches to healing esophagitis.

1 reference

12 December 2020

Long-term management of gastroesophageal reflux disease and its complications

1 reference

12 December 2020

Zollinger-Ellison syndrome: pathogenesis, diagnosis, and management

1 reference

12 December 2020

Efficacy of primed infusions with high dose ranitidine and omeprazole to maintain high intragastric pH in patients with peptic ulcer bleeding: a prospective randomised controlled study

1 reference

12 December 2020

Optimizing the intragastric pH as a supportive therapy in upper GI bleeding

1 reference

12 December 2020

Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis

1 reference

12 December 2020

A review of stress ulcer prophylaxis in the neurosurgical intensive care unit

1 reference

12 December 2020

Lansoprazole. An update of its pharmacological properties and clinical efficacy in the management of acid-related disorders

1 reference

12 December 2020

Gastroesophageal reflux disease. Pill, blade, or laparoscope?

1 reference

12 December 2020

A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy

1 reference

12 December 2020

Proton-pump inhibitors for gastric acid-related disease.

1 reference

12 December 2020

A prospective study of omeprazole suspension to prevent clinically significant gastrointestinal bleeding from stress ulcers in mechanically ventilated trauma patients

1 reference

12 December 2020

The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain

1 reference

12 December 2020

Proton pump inhibitors. Pharmacology and rationale for use in gastrointestinal disorders

1 reference

12 December 2020

Equipotent inhibition of gastric acid secretion by equal doses of oral or intravenous pantoprazole

1 reference

12 December 2020

Proton-pump inhibitors in acid-related diseases.

1 reference

12 December 2020

Optimization of acid suppression for patients with peptic ulcer bleeding: an intragastric pH-metry study with omeprazole.

1 reference

12 December 2020

Double-blind comparison [correction of Double-blind, placebo-controlled comparison] of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of erosive or ulcerative gastro-oesophageal reflux disease. The European Rabeprazole Study Group

1 reference

12 December 2020

Correlation of ambulatory 24-hour esophageal pH monitoring results with symptom improvement in patients with noncardiac chest pain due to gastroesophageal reflux disease

1 reference

12 December 2020

Recognizing atypical manifestations of GERD. Asthma, chest pain, and otolaryngologic disorders may be due to reflux

1 reference

12 December 2020

Symptomatic gastroesophageal reflux in acutely hospitalized patients.

1 reference

12 December 2020

10.1097/00004836-200101000-00007

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6746342&resulttype=core&format=json

12 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6746342&resulttype=core&format=json

12 May 2020

PubMed publication ID

11154164

1 reference